Osmotica Pharmaceuticals plc to Present at Jefferies London Virtual Healthcare Conference 2021
2021年11月15日 - 8:50PM
Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“Osmotica” or the
“Company”), a specialty pharmaceutical company, announced today
that Brian Markison, Chief Executive Officer, James “JD” Schaub,
Chief Operating Officer, and Andrew Einhorn, Chief Financial
Officer, will present at the Jefferies London Virtual Healthcare
Conference 2021 as follows:
Date: |
Thursday,
November 18, 2021 |
On Demand Time: |
8:00AM GMT (3:00AM ET) |
Webcast: |
https://wsw.com/webcast/jeff201/osmt/1869930 |
The presentation will be webcast on-demand and
available for 30 days thereafter using the link provided above and
via the Company’s website at www.osmotica.com under the “Investor
& News” section.
About Osmotica Pharmaceuticals
plcOsmotica Pharmaceuticals plc (Nasdaq: OSMT) is a
specialty pharmaceutical company focused on the development and
commercialization of products that target markets with underserved
patient populations. RVL Pharmaceuticals, Inc. is the Company’s
ophthalmic subsidiary supporting UPNEEQ®.
Osmotica has operations in the United States and
Hungary.
Investor and Media Relations for Osmotica
Pharmaceuticals plcLisa M. WilsonIn-Site Communications,
Inc.T: 212-452-2793E: lwilson@insitecony.com
Osmotica Pharmaceuticals (NASDAQ:OSMT)
過去 株価チャート
から 11 2024 まで 12 2024
Osmotica Pharmaceuticals (NASDAQ:OSMT)
過去 株価チャート
から 12 2023 まで 12 2024
Real-Time news about Osmotica Pharmaceuticals PLC (ナスダック市場): 0 recent articles
その他のニュース記事